ImageneBio, Inc. — Form 10-Q
Filed August 5, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
This is ImageneBio's Form 10-Q for the period ended June 30, 2026, filed August 5, 2026. The filing document metadata shows 60 supporting documents totaling approximately 12.9 MB. The 10-Q itself (ima-20260630.htm) is 2.8 MB. No specific financial figures, operational developments, cash balances, revenue, losses, clinical trial results, capital raises, or business changes are disclosed in the provided filing header.
Why this rating
Standard quarterly filing submission. No material business events, financial data, or operational changes are present in this document header excerpt to assess against the $41.7M market cap.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.